chr12-130399745-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001393629.1(RIMBP2):āc.3834A>Cā(p.Glu1278Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000675 in 1,614,068 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001393629.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RIMBP2 | NM_001393629.1 | c.3834A>C | p.Glu1278Asp | missense_variant | 22/23 | ENST00000690449.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RIMBP2 | ENST00000690449.1 | c.3834A>C | p.Glu1278Asp | missense_variant | 22/23 | NM_001393629.1 | P5 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000115 AC: 29AN: 251474Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135908
GnomAD4 exome AF: 0.0000684 AC: 100AN: 1461866Hom.: 0 Cov.: 31 AF XY: 0.0000674 AC XY: 49AN XY: 727232
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.3066A>C (p.E1022D) alteration is located in exon 18 (coding exon 16) of the RIMBP2 gene. This alteration results from a A to C substitution at nucleotide position 3066, causing the glutamic acid (E) at amino acid position 1022 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at